The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...

The publication, titled “ Comparative characterization of Cas12f orthologs reveals mechanistic features underlying enhanced genome editing efficiency” highlights the potential of MG119-28 (formally ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...

Researchers have developed a smaller pair of “molecular scissors” for gene editing, based on a group of enzymes called Cas12f ...

Invasive species represent a $5.4 trillion global problem, with U.S. economic impact alone exceeding $500 billion annually.

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, ...

When CRISPR cuts a gene flanked by short, repeating DNA sequences, the cell’s repair machinery gets confused. It simply zips ...

Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...